H.R. 1 — Budget Reconciliation Act (One Big Beautiful Bill)

H.R. 1 (One Big Beautiful Bill) was signed into law on July 4, 2025, after passing the House under a closed rule and the Senate via reconciliation. The bill covers multiple titles; the two with direct market relevance are Title I (Agriculture, Nutrition, and Forestry) and Title II (Armed Services). The bill is now enacted—all legislative steps are complete. No new hearings, votes, or funding actions remain. The money trail is critical here: Title II authorizes increases for defense shipbuilding (Section 20002) and integrated air/missile defense (Section 20003), but authorization is a ceiling, not an allocation. Actual appropriations require separate annual defense spending bills. Title I, however, does change legal entitlements: it revises the Thrifty Food Plan re-evaluation (Section 10101) and modifies SNAP work requirements (Section 10102), which directly alter federal benefit formulas for nutrition programs. The commodity title (Subtitle C) changes reference prices and marketing loan rates that govern federal payments to producers—this is mandatory spending that does not require annual appropriations. Structural winners and losers: ADM (Archer-Daniels-Midland) processes corn, soybeans, and wheat—all commodities directly affected by the new reference price and loan rate structure. Higher effective price floors benefit ADM's origination margins. Bunge ($BG) faces similar dynamics. On defense, GD's Marine Systems benefits from authorized shipbuilding, but so do Huntington Ingalls ($HII) and General Dynamics' Bath Iron Works. Lockheed Martin ($LMT) and RTX benefit from missile defense authorizations. The bill is net neutral for most sector participants because the real funding decisions remain in separate appropriation bills. Real market data as of April 30, 2026 shows ADM at $74.69 (+7.89% 7-day, +2.75% 30-day), approaching its 52-week high of $74.89. GD at $343.24 (+9.59% 7-day, essentially flat over 30 days). Both stocks have rallied significantly in the past week, but this has no causal connection to a bill signed 10 months ago. Market participants should attribute recent moves to other drivers (Q1 earnings, commodity prices, geopolitical events) rather than legislative tailwinds. Timeline: No further legislative steps remain for H.R. 1. Investors should monitor the FY2027 defense appropriations bills and USDA implementation of the new reference prices for actual cash flow impacts.